{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:56:14Z","timestamp":1777564574593,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1038\/sj.bjc.6605731","type":"journal-article","created":{"date-parts":[[2010,6,15]],"date-time":"2010-06-15T20:02:20Z","timestamp":1276632140000},"page":"6-11","source":"Crossref","is-referenced-by-count":57,"title":["A phase II trial of dose-dense chemotherapy, followed by surgical resection and\/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606)"],"prefix":"10.1038","volume":"103","author":[{"name":"on behalf of JCOG Lung Cancer Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Kunitoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Katakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Nishiwaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Noda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Saijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,15]]},"reference":[{"key":"BF6605731_CR1","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/sj.bjc.6690773","volume":"81","author":"A Berruti","year":"1999","unstructured":"Berruti A, Borasio P, Gerbino A, Gorzegno G, Moschini T, Tampellini M, Ardissone F, Brizzi MP, Dolcetti A, Dogliotti L (1999) Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience. Br J Cancer 81: 841\u2013845","journal-title":"Br J Cancer"},{"key":"BF6605731_CR2","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1200\/JCO.1994.12.7.1484","volume":"12","author":"IF Ciernik","year":"1994","unstructured":"Ciernik IF, Meier U, Lutolf UM (1994) Prognostic factors and outcome of incompletely resected invasive thymoma following radiation therapy. J Clin Oncol 12: 1484\u20131490","journal-title":"J Clin Oncol"},{"key":"BF6605731_CR3","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1200\/JCO.1988.6.11.1722","volume":"6","author":"WJ Curran Jr","year":"1988","unstructured":"Curran Jr WJ, Kornstein MJ, Brooks JJ, Turrisi III AT (1988) Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 6: 1722\u20131727","journal-title":"J Clin Oncol"},{"key":"BF6605731_CR4","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ijrobp.2003.11.021","volume":"59","author":"TY Eng","year":"2004","unstructured":"Eng TY, Fuller CD, Jagirdar J, Bains Y, Thomas Jr CR (2004) Thymic carcinoma: state of the art review. Int J Radiat Oncol Biol Phys 59: 654\u2013664","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF6605731_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/bjc.1997.50","volume":"75","author":"M Fukuoka","year":"1997","unstructured":"Fukuoka M, Masuda N, Negoro S, Matsui K, Yana T, Kudoh S, Kusunoki Y, Takada M, Kawahara M, Ogawara M, Kodama N, Kubota K, Furuse K (1997) CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer. Br J Cancer 75: 306\u2013309","journal-title":"Br J Cancer"},{"key":"BF6605731_CR6","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1200\/JCO.1998.16.6.2126","volume":"16","author":"K Furuse","year":"1998","unstructured":"Furuse K, Fukuoka M, Nishiwaki Y, Kurita Y, Watanabe K, Noda K, Ariyoshi Y, Tamura T, Saijo N (1998) Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group. J Clin Oncol 16: 2126\u20132132","journal-title":"J Clin Oncol"},{"key":"BF6605731_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/01.cco.0000152628.43867.8e","volume":"17","author":"G Giaccone","year":"2005","unstructured":"Giaccone G (2005) Treatment of malignant thymoma. Curr Opin Oncol 17: 140\u2013146","journal-title":"Curr Opin Oncol"},{"key":"BF6605731_CR8","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1200\/JCO.1996.14.3.814","volume":"14","author":"G Giaccone","year":"1996","unstructured":"Giaccone G, Ardizzoni A, Kirkpatrick A, Clerico M, Sahmoud T, van Zandwijk N (1996) Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 14: 814\u2013820","journal-title":"J Clin Oncol"},{"key":"BF6605731_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/JTO.0b013e31818e105c","volume":"4","author":"N Girard","year":"2009","unstructured":"Girard N, Mornex F, Van Houtte P, Cordier JF, van Schil P (2009) Thymoma: a focus on current therapeutic management. J Thorac Oncol 4: 119\u2013126","journal-title":"J Thorac Oncol"},{"key":"BF6605731_CR10","first-page":"923","volume":"67","author":"JH Goldie","year":"1983","unstructured":"Goldie JH, Coldman AJ (1983) Quantitative model for multiple levels of drug resistance in clinical tumors. Cancer Treat Rep 67: 923\u2013931","journal-title":"Cancer Treat Rep"},{"key":"BF6605731_CR11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.lungcan.2003.12.010","volume":"44","author":"ES Kim","year":"2004","unstructured":"Kim ES, Putnam JB, Komaki R, Walsh GL, Ro JY, Shin HJ, Truong M, Moon H, Swisher SG, Fossella FV, Khuri FR, Hong WK, Shin DM (2004) Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 44: 369\u2013379","journal-title":"Lung Cancer"},{"key":"BF6605731_CR12","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/sj.bjc.6605347","volume":"101","author":"H Kunitoh","year":"2009","unstructured":"Kunitoh H, Tamura T, Shibata T, Nakagawa K, Takeda K, Nishiwaki Y, Osaki Y, Noda K, Yokoyama A, Saijo N (2009) A phase-II trial of dose-dense chemotherapy in patients with disseminated thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9605). Br J Cancer 101: 1549\u20131554","journal-title":"Br J Cancer"},{"key":"BF6605731_CR13","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1200\/JCO.1987.5.5.756","volume":"5","author":"L Levin","year":"1987","unstructured":"Levin L, Hryniuk WM (1987) Dose intensity analysis of chemotherapy regimens in ovarian carcinoma. J Clin Oncol 5: 756\u2013767","journal-title":"J Clin Oncol"},{"key":"BF6605731_CR14","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.ejso.2006.03.049","volume":"32","author":"HC Liu","year":"2006","unstructured":"Liu HC, Chen YJ, Tzen CY, Huang CJ, Chang CC, Huang WC (2006) Debulking surgery for advanced thymoma. Eur J Surg Oncol 32: 1000\u20131005","journal-title":"Eur J Surg Oncol"},{"key":"BF6605731_CR15","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1200\/JCO.1997.15.9.3093","volume":"15","author":"PJ Loehrer Sr","year":"1997","unstructured":"Loehrer Sr PJ, Chen M, Kim K, Aisner SC, Einhorn LH, Livingston R, Johnson D (1997) Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol 15: 3093\u20133099","journal-title":"J Clin Oncol"},{"key":"BF6605731_CR16","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1002\/1097-0142(20010601)91:11<2010::AID-CNCR1226>3.0.CO;2-2","volume":"91","author":"PJ Loehrer Sr","year":"2001","unstructured":"Loehrer Sr PJ, Jiroutek M, Aisner S, Aisner J, Green M, Thomas Jr CR, Livingston R, Johnson DH (2001) Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Cancer 91: 2010\u20132015","journal-title":"Cancer"},{"key":"BF6605731_CR17","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1200\/JCO.1994.12.6.1164","volume":"12","author":"PJ Loehrer Sr","year":"1994","unstructured":"Loehrer Sr PJ, Kim K, Aisner SC, Livingston R, Einhorn LH, Johnson D, Blum R (1994) Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol 12: 1164\u20131168","journal-title":"J Clin Oncol"},{"key":"BF6605731_CR18","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/01243894-200605000-00007","volume":"1","author":"M Lucchi","year":"2006","unstructured":"Lucchi M, Melfi F, Dini P, Basolo F, Viti A, Givigliano F, Angeletti CA, Mussi A (2006) Neoadjuvant chemotherapy for stage III and IVA thymomas: a single-institution experience with a long follow-up. J Thorac Oncol 1: 308\u2013313","journal-title":"J Thorac Oncol"},{"key":"BF6605731_CR19","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.athoracsur.2004.12.051","volume":"79","author":"AA Mangi","year":"2005","unstructured":"Mangi AA, Wain JC, Donahue DM, Grillo HC, Mathisen DJ, Wright CD (2005) Adjuvant radiation of stage III thymoma: is it necessary? Ann Thorac Surg 79: 1834\u20131839","journal-title":"Ann Thorac Surg"},{"key":"BF6605731_CR20","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","volume":"48","author":"A Masaoka","year":"1981","unstructured":"Masaoka A, Monden Y, Nakahara K, Tanioka T (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer 48: 2485\u20132492","journal-title":"Cancer"},{"key":"BF6605731_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47: 207\u2013214","journal-title":"Cancer"},{"key":"BF6605731_CR22","first-page":"20","volume":"14","author":"N Murray","year":"1987","unstructured":"Murray N (1987) The importance of dose and dose intensity in lung cancer chemotherapy. Semin Oncol 14: 20\u201328","journal-title":"Semin Oncol"},{"key":"BF6605731_CR23","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1200\/JCO.1991.9.9.1632","volume":"9","author":"N Murray","year":"1991","unstructured":"Murray N, Shah A, Osoba D, Page R, Karsai H, Grafton C, Goddard K, Fairey R, Voss N (1991) Intensive weekly chemotherapy for the treatment of extensive-stage small-cell lung cancer. J Clin Oncol 9: 1632\u20131638","journal-title":"J Clin Oncol"},{"key":"BF6605731_CR24","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/cncr.10373","volume":"94","author":"K Ogawa","year":"2002","unstructured":"Ogawa K, Uno T, Toita T, Onishi H, Yoshida H, Kakinohana Y, Adachi G, Itami J, Ito H, Murayama S (2002) Postoperative radiotherapy for patients with completely resected thymoma: a multi-institutional, retrospective review of 103 patients. Cancer 94: 1405\u20131413","journal-title":"Cancer"},{"key":"BF6605731_CR25","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/cncr.10226","volume":"94","author":"M Okumura","year":"2002","unstructured":"Okumura M, Ohta M, Tateyama H, Nakagawa K, Matsumura A, Maeda H, Tada H, Eimoto T, Matsuda H, Masaoka A (2002) The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 94: 624\u2013632","journal-title":"Cancer"},{"key":"BF6605731_CR26","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0022-5223(96)70265-9","volume":"112","author":"JF Regnard","year":"1996","unstructured":"Regnard JF, Magdeleinat P, Dromer C, Dulmet E, de Montpreville V, Levi JF, Levasseur P (1996) Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 112: 376\u2013384","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF6605731_CR27","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1200\/JCO.2004.10.113","volume":"22","author":"P Strobel","year":"2004","unstructured":"Strobel P, Bauer A, Puppe B, Kraushaar T, Krein A, Toyka K, Gold R, Semik M, Kiefer R, Nix W, Schalke B, Muller-Hermelink HK, Marx A (2004) Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol 22: 1501\u20131509","journal-title":"J Clin Oncol"},{"key":"BF6605731_CR28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/oxfordjournals.jjco.a039642","volume":"23","author":"K Tobinai","year":"1993","unstructured":"Tobinai K, Kohno A, Shimada Y, Watanabe T, Tamura T, Takeyama K, Narabayashi M, Fukutomi T, Kondo H, Shimoyama M, Suemasu K (1993) Toxicity grading criteria of the Japan Clinical Oncology Group. The Clinical Trial Review Committee of the Japan Clinical Oncology Group. Jpn J Clin Oncol 23: 250\u2013257","journal-title":"Jpn J Clin Oncol"},{"key":"BF6605731_CR29","volume-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart","author":"WB Travis","year":"2004","unstructured":"Travis WB, Brambilla E, Muller-Hermelinck HK, Harris CC (2004) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press: Lyon"},{"key":"BF6605731_CR30","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0167-8140(90)90154-O","volume":"19","author":"A Urgesi","year":"1990","unstructured":"Urgesi A, Monetti U, Rossi G, Ricardi U, Casadio C (1990) Role of radiation therapy in locally advanced thymoma. Radiother Oncol 19: 273\u2013280","journal-title":"Radiother Oncol"},{"key":"BF6605731_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/JTO.0b013e31802bafc8","volume":"2","author":"K Yokoi","year":"2007","unstructured":"Yokoi K, Matsuguma H, Nakahara R, Kondo T, Kamiyama Y, Mori K, Miyazawa N (2007) Multidisciplinary treatment for advanced invasive thymoma with cisplatin, doxorubicin, and methylprednisolone. J Thorac Oncol 2: 73\u201378","journal-title":"J Thorac Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6605731.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605731","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605731.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:45:36Z","timestamp":1684413936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6605731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["BF6605731"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6605731","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}